[{"edinetCode":"E00885","endDate":"2017\/3\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":967.0,"averageTemporaryStaff":183.0,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":19417000.0,"sharesOwendPercent":0.3635,"outstandingShares":null,"numberOfSubsidiary":11.0,"bps":529.94,"equityRatio":0.389,"cashAndCashEquivalents":9296000000.0,"assets":69046000000.0,"currentAssets":35947000000.0,"fixedAsset":33098000000.0,"tangibleFixedAssets":28390000000.0,"intangibleFixedAssets":387000000.0,"investmentAndOtherAssets":4320000000.0,"liabilities":41001000000.0,"currentLiabilities":20547000000.0,"shorTermDept":6001000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":20454000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":18593000000.0,"netAsset":28044000000.0,"capitalStock":26293000000.0,"capital":8895000000.0,"capitalSurplus":7218000000.0,"accumulatedEarnings":11300000000.0,"treasuryStock":-1120000000.0,"valuationAndConversionAdjustments":561000000.0,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":52254000000.0,"costOfSales":38532000000.0,"grossProfit":13721000000.0,"sgaExpenses":9777000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":2393000000.0,"operatingIncome":3944000000.0,"nonOperatingIncome":261000000.0,"nonOperatingExpenses":432000000.0,"interestExpense":274000000.0,"ordinaryProfit":3773000000.0,"extraordinaryGain":55000000.0,"extraordinaryLoss":281000000.0,"incomeBeforeTax":3547000000.0,"incomeTaxes":915000000.0,"netIncome":2632000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":2489000000.0,"comprehensiveIncome":2857000000.0,"eps":47.4,"dilutedEps":47.36,"dividendPerShare":null,"per":9.0,"roe":0.095,"cashFlowFromOperatingActivities":3750000000.0,"depreciationAndCashflowFromOperatingActivities":2335000000.0,"cashFlowFromInvestingActivities":-3336000000.0,"cashFlowFromFinancialActivities":-477000000.0,"changesInCashAndCashEquivalents":-105000000.0,"列1":"asr","submitDate":"2017\/6\/27","stockCode":4461,"accountingYear":"第153期（自　平成28年４月１日　至　平成29年３月31日）","accountingYearStart":"2016\/4\/1","accountingYearEnd":"2017\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00885","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":8895,"settlementDate":"2022\/3\/31","submitterName":"第一工業製薬株式会社","submitterNameEnglish":"DKS Co. Ltd.","submitterNameKana":"ダイイチコウギョウセイヤクカブシガイシャ","location":"京都市下京区西七条東久保町５５番地","industory":"化学","corporateNumber":7130000000000.0},{"edinetCode":"E00885","endDate":"2018\/3\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":976.0,"averageTemporaryStaff":197.0,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":22248000.0,"sharesOwendPercent":0.4383,"outstandingShares":null,"numberOfSubsidiary":11.0,"bps":594.15,"equityRatio":0.408,"cashAndCashEquivalents":11402000000.0,"assets":73976000000.0,"currentAssets":40932000000.0,"fixedAsset":33044000000.0,"tangibleFixedAssets":27584000000.0,"intangibleFixedAssets":378000000.0,"investmentAndOtherAssets":5082000000.0,"liabilities":42015000000.0,"currentLiabilities":22712000000.0,"shorTermDept":6197000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":19303000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":17665000000.0,"netAsset":31960000000.0,"capitalStock":29076000000.0,"capital":8895000000.0,"capitalSurplus":7223000000.0,"accumulatedEarnings":14043000000.0,"treasuryStock":-1086000000.0,"valuationAndConversionAdjustments":1082000000.0,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":56955000000.0,"costOfSales":41896000000.0,"grossProfit":15059000000.0,"sgaExpenses":10006000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":2307000000.0,"operatingIncome":5053000000.0,"nonOperatingIncome":238000000.0,"nonOperatingExpenses":566000000.0,"interestExpense":242000000.0,"ordinaryProfit":4725000000.0,"extraordinaryGain":1098000000.0,"extraordinaryLoss":314000000.0,"incomeBeforeTax":5509000000.0,"incomeTaxes":1496000000.0,"netIncome":4012000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":3351000000.0,"comprehensiveIncome":4593000000.0,"eps":66.06,"dilutedEps":66.05,"dividendPerShare":null,"per":13.2,"roe":0.118,"cashFlowFromOperatingActivities":5017000000.0,"depreciationAndCashflowFromOperatingActivities":2473000000.0,"cashFlowFromInvestingActivities":-1130000000.0,"cashFlowFromFinancialActivities":-1858000000.0,"changesInCashAndCashEquivalents":2106000000.0,"列1":"asr","submitDate":"2018\/6\/26","stockCode":4461,"accountingYear":"第154期（自　平成29年４月１日　至　平成30年３月31日）","accountingYearStart":"2017\/4\/1","accountingYearEnd":"2018\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00885","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":8895,"settlementDate":"2022\/3\/31","submitterName":"第一工業製薬株式会社","submitterNameEnglish":"DKS Co. Ltd.","submitterNameKana":"ダイイチコウギョウセイヤクカブシガイシャ","location":"京都市下京区西七条東久保町５５番地","industory":"化学","corporateNumber":7130000000000.0},{"edinetCode":"E00885","endDate":"2019\/3\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":985.0,"averageTemporaryStaff":208.0,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":4767000.0,"sharesOwendPercent":0.4692,"outstandingShares":null,"numberOfSubsidiary":11.0,"bps":3082.83,"equityRatio":0.413,"cashAndCashEquivalents":7278000000.0,"assets":75906000000.0,"currentAssets":39361000000.0,"fixedAsset":36545000000.0,"tangibleFixedAssets":29724000000.0,"intangibleFixedAssets":1348000000.0,"investmentAndOtherAssets":5472000000.0,"liabilities":42315000000.0,"currentLiabilities":24220000000.0,"shorTermDept":6604000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":18095000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":16862000000.0,"netAsset":33591000000.0,"capitalStock":30998000000.0,"capital":8895000000.0,"capitalSurplus":7237000000.0,"accumulatedEarnings":15934000000.0,"treasuryStock":-1068000000.0,"valuationAndConversionAdjustments":325000000.0,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":59574000000.0,"costOfSales":44130000000.0,"grossProfit":15444000000.0,"sgaExpenses":11103000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":2765000000.0,"operatingIncome":4341000000.0,"nonOperatingIncome":251000000.0,"nonOperatingExpenses":417000000.0,"interestExpense":196000000.0,"ordinaryProfit":4175000000.0,"extraordinaryGain":141000000.0,"extraordinaryLoss":337000000.0,"incomeBeforeTax":3979000000.0,"incomeTaxes":1168000000.0,"netIncome":2810000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":2581000000.0,"comprehensiveIncome":1945000000.0,"eps":254.11,"dilutedEps":null,"dividendPerShare":null,"per":13.7,"roe":0.084,"cashFlowFromOperatingActivities":3236000000.0,"depreciationAndCashflowFromOperatingActivities":2555000000.0,"cashFlowFromInvestingActivities":-5694000000.0,"cashFlowFromFinancialActivities":-1510000000.0,"changesInCashAndCashEquivalents":-4123000000.0,"列1":"asr","submitDate":"2019\/6\/25","stockCode":4461,"accountingYear":"第155期（自　2018年４月１日　至　2019年３月31日）","accountingYearStart":"2018\/4\/1","accountingYearEnd":"2019\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00885","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":8895,"settlementDate":"2022\/3\/31","submitterName":"第一工業製薬株式会社","submitterNameEnglish":"DKS Co. Ltd.","submitterNameKana":"ダイイチコウギョウセイヤクカブシガイシャ","location":"京都市下京区西七条東久保町５５番地","industory":"化学","corporateNumber":7130000000000.0},{"edinetCode":"E00885","endDate":"2019\/6\/30","Report abbreviation_x":"q1r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.401,"cashAndCashEquivalents":null,"assets":76459000000.0,"currentAssets":39628000000.0,"fixedAsset":36831000000.0,"tangibleFixedAssets":30282000000.0,"intangibleFixedAssets":1314000000.0,"investmentAndOtherAssets":5234000000.0,"liabilities":43482000000.0,"currentLiabilities":26616000000.0,"shorTermDept":9751000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":16865000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":15448000000.0,"netAsset":32977000000.0,"capitalStock":30569000000.0,"capital":8895000000.0,"capitalSurplus":7237000000.0,"accumulatedEarnings":15505000000.0,"treasuryStock":-1068000000.0,"valuationAndConversionAdjustments":122000000.0,"Report abbreviation_y":"q1r","context_y":"当四半期累計期間連結期間","Sales":15065000000.0,"costOfSales":11605000000.0,"grossProfit":3460000000.0,"sgaExpenses":2900000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":559000000.0,"nonOperatingIncome":49000000.0,"nonOperatingExpenses":86000000.0,"interestExpense":47000000.0,"ordinaryProfit":523000000.0,"extraordinaryGain":null,"extraordinaryLoss":20000000.0,"incomeBeforeTax":502000000.0,"incomeTaxes":162000000.0,"netIncome":340000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":282000000.0,"comprehensiveIncome":131000000.0,"eps":27.76,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q1r","submitDate":"2019\/8\/9","stockCode":4461,"accountingYear":null,"accountingYearStart":"2019\/4\/1","accountingYearEnd":"2020\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00885","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":8895,"settlementDate":"2022\/3\/31","submitterName":"第一工業製薬株式会社","submitterNameEnglish":"DKS Co. Ltd.","submitterNameKana":"ダイイチコウギョウセイヤクカブシガイシャ","location":"京都市下京区西七条東久保町５５番地","industory":"化学","corporateNumber":7130000000000.0},{"edinetCode":"E00885","endDate":"2019\/9\/30","Report abbreviation_x":"q2r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":5092000.0,"sharesOwendPercent":0.5007,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.39,"cashAndCashEquivalents":11110000000.0,"assets":80274000000.0,"currentAssets":42514000000.0,"fixedAsset":37759000000.0,"tangibleFixedAssets":31390000000.0,"intangibleFixedAssets":1268000000.0,"investmentAndOtherAssets":5100000000.0,"liabilities":46661000000.0,"currentLiabilities":25446000000.0,"shorTermDept":9534000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":21215000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":19808000000.0,"netAsset":33612000000.0,"capitalStock":31250000000.0,"capital":8895000000.0,"capitalSurplus":7250000000.0,"accumulatedEarnings":16154000000.0,"treasuryStock":-1050000000.0,"valuationAndConversionAdjustments":63000000.0,"Report abbreviation_y":"q2r","context_y":"当四半期累計期間連結期間","Sales":30399000000.0,"costOfSales":23049000000.0,"grossProfit":7350000000.0,"sgaExpenses":5759000000.0,"salaryAndBenefit":1062000000.0,"depreciationAndSGA":144000000.0,"RDExpenses":1435000000.0,"operatingIncome":1590000000.0,"nonOperatingIncome":115000000.0,"nonOperatingExpenses":161000000.0,"interestExpense":94000000.0,"ordinaryProfit":1545000000.0,"extraordinaryGain":null,"extraordinaryLoss":41000000.0,"incomeBeforeTax":1503000000.0,"incomeTaxes":433000000.0,"netIncome":1070000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":930000000.0,"comprehensiveIncome":742000000.0,"eps":91.55,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":1946000000.0,"depreciationAndCashflowFromOperatingActivities":1315000000.0,"cashFlowFromInvestingActivities":-3113000000.0,"cashFlowFromFinancialActivities":5058000000.0,"changesInCashAndCashEquivalents":3831000000.0,"列1":"q2r","submitDate":"2019\/11\/13","stockCode":4461,"accountingYear":null,"accountingYearStart":"2019\/4\/1","accountingYearEnd":"2020\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00885","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":8895,"settlementDate":"2022\/3\/31","submitterName":"第一工業製薬株式会社","submitterNameEnglish":"DKS Co. Ltd.","submitterNameKana":"ダイイチコウギョウセイヤクカブシガイシャ","location":"京都市下京区西七条東久保町５５番地","industory":"化学","corporateNumber":7130000000000.0},{"edinetCode":"E00885","endDate":"2019\/12\/31","Report abbreviation_x":"q3r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.391,"cashAndCashEquivalents":null,"assets":81419000000.0,"currentAssets":43319000000.0,"fixedAsset":38099000000.0,"tangibleFixedAssets":31516000000.0,"intangibleFixedAssets":1200000000.0,"investmentAndOtherAssets":5382000000.0,"liabilities":47203000000.0,"currentLiabilities":27610000000.0,"shorTermDept":9953000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":19593000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":18107000000.0,"netAsset":34215000000.0,"capitalStock":31543000000.0,"capital":8895000000.0,"capitalSurplus":7250000000.0,"accumulatedEarnings":16448000000.0,"treasuryStock":-1050000000.0,"valuationAndConversionAdjustments":260000000.0,"Report abbreviation_y":"q3r","context_y":"当四半期累計期間連結期間","Sales":46145000000.0,"costOfSales":34739000000.0,"grossProfit":11405000000.0,"sgaExpenses":8568000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":2836000000.0,"nonOperatingIncome":150000000.0,"nonOperatingExpenses":237000000.0,"interestExpense":146000000.0,"ordinaryProfit":2749000000.0,"extraordinaryGain":null,"extraordinaryLoss":126000000.0,"incomeBeforeTax":2622000000.0,"incomeTaxes":789000000.0,"netIncome":1833000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":1580000000.0,"comprehensiveIncome":1702000000.0,"eps":155.46,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q3r","submitDate":"2020\/2\/13","stockCode":4461,"accountingYear":null,"accountingYearStart":"2019\/4\/1","accountingYearEnd":"2020\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00885","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":8895,"settlementDate":"2022\/3\/31","submitterName":"第一工業製薬株式会社","submitterNameEnglish":"DKS Co. Ltd.","submitterNameKana":"ダイイチコウギョウセイヤクカブシガイシャ","location":"京都市下京区西七条東久保町５５番地","industory":"化学","corporateNumber":7130000000000.0},{"edinetCode":"E00885","endDate":"2020\/3\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":1032.0,"averageTemporaryStaff":269.0,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":5700000.0,"sharesOwendPercent":0.5605,"outstandingShares":null,"numberOfSubsidiary":11.0,"bps":3114.97,"equityRatio":0.388,"cashAndCashEquivalents":10126000000.0,"assets":81736000000.0,"currentAssets":42595000000.0,"fixedAsset":39141000000.0,"tangibleFixedAssets":33274000000.0,"intangibleFixedAssets":1130000000.0,"investmentAndOtherAssets":4737000000.0,"liabilities":47470000000.0,"currentLiabilities":23644000000.0,"shorTermDept":7273000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":23826000000.0,"bonds":6000000000.0,"convertibleBond":null,"commercialPaper":null,"longTermDebts":16672000000.0,"netAsset":34265000000.0,"capitalStock":31977000000.0,"capital":8895000000.0,"capitalSurplus":7250000000.0,"accumulatedEarnings":16882000000.0,"treasuryStock":-1051000000.0,"valuationAndConversionAdjustments":-299000000.0,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":61456000000.0,"costOfSales":45991000000.0,"grossProfit":15465000000.0,"sgaExpenses":11310000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":2748000000.0,"operatingIncome":4154000000.0,"nonOperatingIncome":258000000.0,"nonOperatingExpenses":888000000.0,"interestExpense":200000000.0,"ordinaryProfit":3524000000.0,"extraordinaryGain":null,"extraordinaryLoss":160000000.0,"incomeBeforeTax":3364000000.0,"incomeTaxes":1013000000.0,"netIncome":2350000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":2014000000.0,"comprehensiveIncome":1752000000.0,"eps":198.17,"dilutedEps":null,"dividendPerShare":null,"per":18.9,"roe":0.064,"cashFlowFromOperatingActivities":3766000000.0,"depreciationAndCashflowFromOperatingActivities":2724000000.0,"cashFlowFromInvestingActivities":-5842000000.0,"cashFlowFromFinancialActivities":4946000000.0,"changesInCashAndCashEquivalents":2847000000.0,"列1":"asr","submitDate":"2020\/6\/24","stockCode":4461,"accountingYear":"第156期（自　2019年４月１日　至　2020年３月31日）","accountingYearStart":"2019\/4\/1","accountingYearEnd":"2020\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00885","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":8895,"settlementDate":"2022\/3\/31","submitterName":"第一工業製薬株式会社","submitterNameEnglish":"DKS Co. Ltd.","submitterNameKana":"ダイイチコウギョウセイヤクカブシガイシャ","location":"京都市下京区西七条東久保町５５番地","industory":"化学","corporateNumber":7130000000000.0},{"edinetCode":"E00885","endDate":"2020\/6\/30","Report abbreviation_x":"q1r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.398,"cashAndCashEquivalents":null,"assets":80338000000.0,"currentAssets":39261000000.0,"fixedAsset":41077000000.0,"tangibleFixedAssets":34459000000.0,"intangibleFixedAssets":1066000000.0,"investmentAndOtherAssets":5551000000.0,"liabilities":45800000000.0,"currentLiabilities":22837000000.0,"shorTermDept":7818000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":22962000000.0,"bonds":6000000000.0,"convertibleBond":null,"commercialPaper":null,"longTermDebts":15770000000.0,"netAsset":34538000000.0,"capitalStock":31962000000.0,"capital":8895000000.0,"capitalSurplus":7250000000.0,"accumulatedEarnings":16867000000.0,"treasuryStock":-1051000000.0,"valuationAndConversionAdjustments":-18000000.0,"Report abbreviation_y":"q1r","context_y":"当四半期累計期間連結期間","Sales":13632000000.0,"costOfSales":10263000000.0,"grossProfit":3368000000.0,"sgaExpenses":2661000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":707000000.0,"nonOperatingIncome":43000000.0,"nonOperatingExpenses":126000000.0,"interestExpense":49000000.0,"ordinaryProfit":624000000.0,"extraordinaryGain":null,"extraordinaryLoss":25000000.0,"incomeBeforeTax":599000000.0,"incomeTaxes":195000000.0,"netIncome":404000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":340000000.0,"comprehensiveIncome":662000000.0,"eps":33.52,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q1r","submitDate":"2020\/8\/12","stockCode":4461,"accountingYear":null,"accountingYearStart":"2020\/4\/1","accountingYearEnd":"2021\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00885","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":8895,"settlementDate":"2022\/3\/31","submitterName":"第一工業製薬株式会社","submitterNameEnglish":"DKS Co. Ltd.","submitterNameKana":"ダイイチコウギョウセイヤクカブシガイシャ","location":"京都市下京区西七条東久保町５５番地","industory":"化学","corporateNumber":7130000000000.0},{"edinetCode":"E00885","endDate":"2020\/9\/30","Report abbreviation_x":"q2r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":5436000.0,"sharesOwendPercent":0.5343,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.395,"cashAndCashEquivalents":9919000000.0,"assets":83691000000.0,"currentAssets":42029000000.0,"fixedAsset":41662000000.0,"tangibleFixedAssets":34643000000.0,"intangibleFixedAssets":1035000000.0,"investmentAndOtherAssets":5982000000.0,"liabilities":47917000000.0,"currentLiabilities":22978000000.0,"shorTermDept":6988000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":24939000000.0,"bonds":6000000000.0,"convertibleBond":null,"commercialPaper":null,"longTermDebts":14968000000.0,"netAsset":35774000000.0,"capitalStock":32664000000.0,"capital":8895000000.0,"capitalSurplus":7267000000.0,"accumulatedEarnings":17541000000.0,"treasuryStock":-1040000000.0,"valuationAndConversionAdjustments":383000000.0,"Report abbreviation_y":"q2r","context_y":"当四半期累計期間連結期間","Sales":28012000000.0,"costOfSales":20928000000.0,"grossProfit":7084000000.0,"sgaExpenses":5307000000.0,"salaryAndBenefit":1079000000.0,"depreciationAndSGA":125000000.0,"RDExpenses":1376000000.0,"operatingIncome":1777000000.0,"nonOperatingIncome":112000000.0,"nonOperatingExpenses":227000000.0,"interestExpense":100000000.0,"ordinaryProfit":1662000000.0,"extraordinaryGain":null,"extraordinaryLoss":35000000.0,"incomeBeforeTax":1627000000.0,"incomeTaxes":445000000.0,"netIncome":1181000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":1014000000.0,"comprehensiveIncome":1877000000.0,"eps":99.77,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":1543000000.0,"depreciationAndCashflowFromOperatingActivities":1535000000.0,"cashFlowFromInvestingActivities":-2090000000.0,"cashFlowFromFinancialActivities":350000000.0,"changesInCashAndCashEquivalents":-207000000.0,"列1":"q2r","submitDate":"2020\/11\/11","stockCode":4461,"accountingYear":null,"accountingYearStart":"2020\/4\/1","accountingYearEnd":"2021\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00885","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":8895,"settlementDate":"2022\/3\/31","submitterName":"第一工業製薬株式会社","submitterNameEnglish":"DKS Co. Ltd.","submitterNameKana":"ダイイチコウギョウセイヤクカブシガイシャ","location":"京都市下京区西七条東久保町５５番地","industory":"化学","corporateNumber":7130000000000.0},{"edinetCode":"E00885","endDate":"2020\/12\/31","Report abbreviation_x":"q3r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.388,"cashAndCashEquivalents":null,"assets":86249000000.0,"currentAssets":44612000000.0,"fixedAsset":41637000000.0,"tangibleFixedAssets":34518000000.0,"intangibleFixedAssets":971000000.0,"investmentAndOtherAssets":6147000000.0,"liabilities":49961000000.0,"currentLiabilities":22747000000.0,"shorTermDept":6746000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":27213000000.0,"bonds":6000000000.0,"convertibleBond":null,"commercialPaper":null,"longTermDebts":17215000000.0,"netAsset":36288000000.0,"capitalStock":32954000000.0,"capital":8895000000.0,"capitalSurplus":7267000000.0,"accumulatedEarnings":17831000000.0,"treasuryStock":-1040000000.0,"valuationAndConversionAdjustments":510000000.0,"Report abbreviation_y":"q3r","context_y":"当四半期累計期間連結期間","Sales":43380000000.0,"costOfSales":32348000000.0,"grossProfit":11031000000.0,"sgaExpenses":8051000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":2980000000.0,"nonOperatingIncome":168000000.0,"nonOperatingExpenses":336000000.0,"interestExpense":151000000.0,"ordinaryProfit":2813000000.0,"extraordinaryGain":null,"extraordinaryLoss":121000000.0,"incomeBeforeTax":2691000000.0,"incomeTaxes":760000000.0,"netIncome":1930000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":1661000000.0,"comprehensiveIncome":2748000000.0,"eps":163.29,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q3r","submitDate":"2021\/2\/10","stockCode":4461,"accountingYear":null,"accountingYearStart":"2020\/4\/1","accountingYearEnd":"2021\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00885","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":8895,"settlementDate":"2022\/3\/31","submitterName":"第一工業製薬株式会社","submitterNameEnglish":"DKS Co. Ltd.","submitterNameKana":"ダイイチコウギョウセイヤクカブシガイシャ","location":"京都市下京区西七条東久保町５５番地","industory":"化学","corporateNumber":7130000000000.0},{"edinetCode":"E00885","endDate":"2021\/3\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":1061.0,"averageTemporaryStaff":264.0,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":5241000.0,"sharesOwendPercent":0.5152,"outstandingShares":null,"numberOfSubsidiary":11.0,"bps":3405.28,"equityRatio":0.407,"cashAndCashEquivalents":11531000000.0,"assets":85033000000.0,"currentAssets":43997000000.0,"fixedAsset":41035000000.0,"tangibleFixedAssets":34317000000.0,"intangibleFixedAssets":833000000.0,"investmentAndOtherAssets":5884000000.0,"liabilities":47628000000.0,"currentLiabilities":22071000000.0,"shorTermDept":6698000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":25556000000.0,"bonds":6000000000.0,"convertibleBond":null,"commercialPaper":null,"longTermDebts":15831000000.0,"netAsset":37404000000.0,"capitalStock":33856000000.0,"capital":8895000000.0,"capitalSurplus":7267000000.0,"accumulatedEarnings":18733000000.0,"treasuryStock":-1040000000.0,"valuationAndConversionAdjustments":791000000.0,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":59140000000.0,"costOfSales":43961000000.0,"grossProfit":15179000000.0,"sgaExpenses":10693000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":2821000000.0,"operatingIncome":4485000000.0,"nonOperatingIncome":246000000.0,"nonOperatingExpenses":418000000.0,"interestExpense":202000000.0,"ordinaryProfit":4314000000.0,"extraordinaryGain":408000000.0,"extraordinaryLoss":963000000.0,"incomeBeforeTax":3759000000.0,"incomeTaxes":1010000000.0,"netIncome":2749000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":2563000000.0,"comprehensiveIncome":3864000000.0,"eps":251.97,"dilutedEps":null,"dividendPerShare":null,"per":14.6,"roe":0.077,"cashFlowFromOperatingActivities":4955000000.0,"depreciationAndCashflowFromOperatingActivities":3263000000.0,"cashFlowFromInvestingActivities":-3804000000.0,"cashFlowFromFinancialActivities":255000000.0,"changesInCashAndCashEquivalents":1405000000.0,"列1":"asr","submitDate":"2021\/6\/25","stockCode":4461,"accountingYear":"第157期（自　2020年４月１日　至　2021年３月31日）","accountingYearStart":"2020\/4\/1","accountingYearEnd":"2021\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00885","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":8895,"settlementDate":"2022\/3\/31","submitterName":"第一工業製薬株式会社","submitterNameEnglish":"DKS Co. Ltd.","submitterNameKana":"ダイイチコウギョウセイヤクカブシガイシャ","location":"京都市下京区西七条東久保町５５番地","industory":"化学","corporateNumber":7130000000000.0},{"edinetCode":"E00885","endDate":"2021\/6\/30","Report abbreviation_x":"q1r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.418,"cashAndCashEquivalents":null,"assets":83113000000.0,"currentAssets":42221000000.0,"fixedAsset":40892000000.0,"tangibleFixedAssets":34434000000.0,"intangibleFixedAssets":787000000.0,"investmentAndOtherAssets":5670000000.0,"liabilities":45385000000.0,"currentLiabilities":21375000000.0,"shorTermDept":6734000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":24010000000.0,"bonds":6000000000.0,"convertibleBond":null,"commercialPaper":null,"longTermDebts":14355000000.0,"netAsset":37728000000.0,"capitalStock":33975000000.0,"capital":8895000000.0,"capitalSurplus":7267000000.0,"accumulatedEarnings":18852000000.0,"treasuryStock":-1040000000.0,"valuationAndConversionAdjustments":778000000.0,"Report abbreviation_y":"q1r","context_y":"当四半期累計期間連結期間","Sales":14413000000.0,"costOfSales":10654000000.0,"grossProfit":3758000000.0,"sgaExpenses":2663000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":1094000000.0,"nonOperatingIncome":48000000.0,"nonOperatingExpenses":239000000.0,"interestExpense":49000000.0,"ordinaryProfit":903000000.0,"extraordinaryGain":null,"extraordinaryLoss":30000000.0,"incomeBeforeTax":873000000.0,"incomeTaxes":261000000.0,"netIncome":611000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":490000000.0,"comprehensiveIncome":730000000.0,"eps":48.21,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q1r","submitDate":"2021\/8\/6","stockCode":4461,"accountingYear":null,"accountingYearStart":"2021\/4\/1","accountingYearEnd":"2022\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00885","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":8895,"settlementDate":"2022\/3\/31","submitterName":"第一工業製薬株式会社","submitterNameEnglish":"DKS Co. Ltd.","submitterNameKana":"ダイイチコウギョウセイヤクカブシガイシャ","location":"京都市下京区西七条東久保町５５番地","industory":"化学","corporateNumber":7130000000000.0},{"edinetCode":"E00885","endDate":"2021\/12\/31","Report abbreviation_x":"q3r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.426,"cashAndCashEquivalents":null,"assets":84465000000.0,"currentAssets":44406000000.0,"fixedAsset":40059000000.0,"tangibleFixedAssets":33586000000.0,"intangibleFixedAssets":667000000.0,"investmentAndOtherAssets":5805000000.0,"liabilities":45074000000.0,"currentLiabilities":23019000000.0,"shorTermDept":6788000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":22054000000.0,"bonds":6000000000.0,"convertibleBond":null,"commercialPaper":null,"longTermDebts":12575000000.0,"netAsset":39391000000.0,"capitalStock":35018000000.0,"capital":8895000000.0,"capitalSurplus":7278000000.0,"accumulatedEarnings":19866000000.0,"treasuryStock":-1021000000.0,"valuationAndConversionAdjustments":956000000.0,"Report abbreviation_y":"q3r","context_y":"当四半期累計期間連結期間","Sales":46697000000.0,"costOfSales":34741000000.0,"grossProfit":11955000000.0,"sgaExpenses":8230000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":3725000000.0,"nonOperatingIncome":178000000.0,"nonOperatingExpenses":613000000.0,"interestExpense":140000000.0,"ordinaryProfit":3290000000.0,"extraordinaryGain":139000000.0,"extraordinaryLoss":198000000.0,"incomeBeforeTax":3231000000.0,"incomeTaxes":918000000.0,"netIncome":2312000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":1860000000.0,"comprehensiveIncome":2705000000.0,"eps":182.77,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q3r","submitDate":"2022\/2\/8","stockCode":4461,"accountingYear":null,"accountingYearStart":"2021\/4\/1","accountingYearEnd":"2022\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00885","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":8895,"settlementDate":"2022\/3\/31","submitterName":"第一工業製薬株式会社","submitterNameEnglish":"DKS Co. Ltd.","submitterNameKana":"ダイイチコウギョウセイヤクカブシガイシャ","location":"京都市下京区西七条東久保町５５番地","industory":"化学","corporateNumber":7130000000000.0}]